193 related articles for article (PubMed ID: 37648228)
1. Recent progress in vaccine development targeting pre-clinical human toxoplasmosis.
Chu KB; Quan FS
Parasites Hosts Dis; 2023 Aug; 61(3):231-239. PubMed ID: 37648228
[TBL] [Abstract][Full Text] [Related]
2. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
Liu Y; Cao A; Li Y; Li X; Cong H; He S; Zhou H
BMC Infect Dis; 2017 Jun; 17(1):403. PubMed ID: 28592247
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
[TBL] [Abstract][Full Text] [Related]
4. Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice.
Kang HJ; Chu KB; Lee SH; Kim MJ; Park H; Jin H; Quan FS
Korean J Parasitol; 2019 Oct; 57(5):543-547. PubMed ID: 31715698
[TBL] [Abstract][Full Text] [Related]
5. IL-17 and IL-22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB/c mice.
Alizadeh P; Ahmadpour E; Daryani A; Kazemi T; Spotin A; Mahami-Oskouei M; Flynn RJ; Azadi Y; Rajabi S; Sandoghchian S
J Cell Physiol; 2019 Jul; 234(7):10782-10788. PubMed ID: 30565688
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.
Meng M; He S; Zhao G; Bai Y; Zhou H; Cong H; Lu G; Zhao Q; Zhu XQ
Parasit Vectors; 2012 Nov; 5():273. PubMed ID: 23181694
[TBL] [Abstract][Full Text] [Related]
7. Moving towards improved vaccines for Toxoplasma gondii.
Li Y; Zhou H
Expert Opin Biol Ther; 2018 Mar; 18(3):273-280. PubMed ID: 29216783
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.
Wang S; Wang Y; Sun X; Zhang Z; Liu T; Gadahi JA; Hassan IA; Xu L; Yan R; Song X; Li X
BMC Infect Dis; 2015 Oct; 15():448. PubMed ID: 26497908
[TBL] [Abstract][Full Text] [Related]
9. Genetic immunization against toxoplasmosis: A review article.
Yektaeian N; Malekpour A; Atapour A; Davoodi T; Hatam G
Microb Pathog; 2021 Jun; 155():104888. PubMed ID: 33930415
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
[TBL] [Abstract][Full Text] [Related]
11. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
[TBL] [Abstract][Full Text] [Related]
12. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Th17 immune responses of recombinant DNA vaccine encoding GRA14 and ROP13 genes against Toxoplasma gondii in BALB/c mice.
Fatollahzadeh M; Eskandarian A; Darani HY; Pagheh AS; Ahmadpour E
Infect Genet Evol; 2021 Dec; 96():105150. PubMed ID: 34801755
[TBL] [Abstract][Full Text] [Related]
14. Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection.
Kang HJ; Lee SH; Chu KB; Lee DH; Quan FS
Korean J Parasitol; 2018 Oct; 56(5):429-435. PubMed ID: 30419728
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.
Chen J; Li ZY; Huang SY; Petersen E; Song HQ; Zhou DH; Zhu XQ
BMC Infect Dis; 2014 Sep; 14():487. PubMed ID: 25192845
[TBL] [Abstract][Full Text] [Related]
16. A systematic review on efficiency of microneme proteins to induce protective immunity against Toxoplasma gondii.
Dodangeh S; Daryani A; Sharif M; Aghayan SA; Pagheh AS; Sarvi S; Rezaei F
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):617-629. PubMed ID: 30680553
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of a DNA vaccine cocktail encoding ROP13 and GRA14 with Alum nano-adjuvant against Toxoplasma gondii infection in mice.
Pagheh AS; Daryani A; Alizadeh P; Hassannia H; Rodrigues Oliveira SM; Kazemi T; Rezaei F; Pereira ML; Ahmadpour E
Int J Biochem Cell Biol; 2021 Mar; 132():105920. PubMed ID: 33421633
[TBL] [Abstract][Full Text] [Related]
18. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis.
Roque-Reséndiz JL; Rosales R; Herion P
Parasitology; 2004 Apr; 128(Pt 4):397-405. PubMed ID: 15151145
[TBL] [Abstract][Full Text] [Related]
19. Epitope Analysis and Efficacy Evaluation of Phosphatase 2C (PP2C) DNA Vaccine Against Toxoplasma gondii Infection.
Song PX; Yao SH; Yao Y; Zhou J; Li QF; Cao YH; He SY
J Parasitol; 2020 Aug; 106(4):513-521. PubMed ID: 32791522
[TBL] [Abstract][Full Text] [Related]
20. Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis.
Şahar EA; Can H; İz SG; Döşkaya AD; Kalantari-Dehaghi M; Deveci R; Gürüz AY; Döşkaya M
BMC Infect Dis; 2020 Jul; 20(1):493. PubMed ID: 32650739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
